Impact on Hospitalization Derived from the Use of Denosumab for the Prevention of Skeletal-Related Events in Patients with Bone Metastases Secondary to Breast Cancer in Germany

Skeletal-related events (SREs) defined as pathologic fracture, radiation to bone, surgery to bone and spinal cord compression, are common consequences of bone metastasis. Prior studies have shown that SREs increase the utilization of health care resources, including hospitalizations. We estimated the decrease in hospitalizations when a novel superior therapy is used (denosumab), in substitution of zoledronic acid (zol), to treat patients with bone metastases secondary to breast cancer in Germany.

Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: I. Diel, R. Ikenberg, J. Cristino, F. Gatta, Y. Qian, J. Arellano Source Type: research